The global insulin syringes market size is expected to reach USD 2.69 Billion in 2030 and register a revenue CAGR of 6.9% over the forecast period, according to latest report by Reports and Data.
The global insulin syringes market size is expected to reach USD 2.69 Billion in 2030 and register a revenue CAGR of 6.9% over the forecast period, according to latest report by Reports and Data. Rising demand for insulin syringes, due to increase in prevalence of diabetes, is expected to drive market revenue growth during the forecast period. Increasing expenditure on healthcare facilities and medicine is also expected to drive revenue growth of the market over the forecast period. Rising prevalence of diabetes and increasing number of patients suffering from it have considerably increased healthcare spending for treatment. In the past few years, healthcare expenditure rose to almost 3.50 trillion only in the US and is expected to rise further during the forecast period.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/2739
However, rising popularity of insulin pens is expected to hamper market revenue growth during the forecast period. Insulin pens, as compared to insulin syringes, require lesser steps for insulin administration, and most of them come pre-filled with insulin. Therefore, the user just needs to adjust the dosage and inject the insulin. On the other hand, insulin syringes require a better skill set, and chances of mistakes are also high. Majority of diabetes patients have found the use of insulin pens more convenient than conventional syringes. They are easier to use and less painful, which is increasing demand for insulin pens, and this is expected to restrict revenue growth of the global insulin syringes market.
Some Key Highlights in the Report
- The 3/10 cc syringe (0.3 ml) segment is expected to account for largest revenue share over the forecast period. These syringes can hold up to 30 units of insulin and are calibrated in units to avoid any dosage error. Rising prevalence of diabetes and obesity globally, and increasing use of 0.3 ml syringes by patients for injecting insulin are expected to drive revenue growth of this segment during the forecast period.
- Type-2 diabetes segment is expected to account for largest revenue share in the global insulin syringes market between 2022 and 2030. A major percentage of diabetes patients suffers from type-2 diabetes, which was earlier common only among adults, but nowadays, younger children are also being diagnosed with type-2 diabetes. Type-2 diabetes, in most cases, is diagnosed after a long time of onset, which necessitates immediate treatment. This is expected to drive revenue growth of the segment over the forecast period.
- North America insulin syringes market is expected to account for largest revenue share during the forecast period. The US contributed significantly to revenue growth of the North America market, as there is rapid increase in obesity and adoption of unhealthy lifestyles in the country. Supportive government initiatives to prevent and reduce diabetes and other chronic diseases in Canada and Mexico have also contributed to market revenue growth and is expected to continue to do so in the near future.
- In January 2020, Novo Nordisk A/S announced that they got approval from Food and Drug Administration (FDA) for Fiasp, the mealtime insulin for children suffering from diabetes. This initiative was taken to treat and prevent diabetes in younger population.
Competitive Landscape:
The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, merger and acquisitions, collaborations, and joint ventures to gain robust footing in the market.
Top Companies Profiled in the Report:
Nipro Medical Corporation, Biocon Ltd., Terumo Corporation, Cardinal Health Inc., Novo Nordisk A/S, Abbott Laboratories, Becton, Dickinson and Company, Hindustan Syringes and Medical Devices Ltd., Teleflex, and Braun Melsungen.
To know more about the report, visit @ https://www.reportsanddata.com/report-detail/insulin-syringes-market
Insulin Syringes Market Segmentation:
Size Outlook (Revenue, USD Billion; 2019-2030)
- 3/10 cc syringe (0.3ml)
- ½ cc syringe (0.5ml)
- 1 cc syringe (1ml)
Disease Outlook (Revenue, USD Billion; 2019-2030)
- Type-1 Diabetes
- Type-2 Diabetes
Regional Outlook:
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Latin America (Brazil, Rest of LATAM)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/2739
This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.
Explore Latest Trending Research Reports By Reports and Data’s
Medical Processing Seals Market Size, Share And Industry Analysis By Product Type (Gaskets, O-Rings, Lip Seals, Others), By Raw Material Type (Metal, Silicone, Epdm, Ptfe, Nitrile Rubber, Others), By Application Type (Diagnostic devices, Therapeutic equipment, Other medical devices) And Region, Segment Forecasts To 2026
Clinical Chemistry Analyzers Market Size, Share, Analysis By Product Type (Analyzers, Reagents, Others) By Test (Basic Metabolic Panel, Renal Profile, Electrolyte Panel, Lipid Profile, Thyroid Function Panel, Specialty Chemical Panel) End-Use (Hospital, Academic Research Centers, Diagnostic Laboratories, Others), Forecasts to 2026
Electrosurgical/Electrosurgery Devices Market Size, Share & Analysis By Product Type (Electrosurgery Generators, Electrosurgery Instruments & Accessories, Electrosurgery Accessories, Argon, Smoke Management Systems), By Surgery Type (Gynecology, General Surgery, Gastroenterology, Urology, Cardiovascular Surgery, Cosmetic Surgery, Orthopedic Surgery, Neurosurgery), By End Use, Forecasts To 2028
Pharmaceutical Processing Seals Market By Type (O-Rings, Gaskets, Lip Seals, D Seals, and Others), By Material, and By Application (Manufacturing Equipment and Others), 2016-2026
eClinical Solutions Market Analysis, By Product (ECOA, EDC, CDMS, CAP, CDIP, Safety Solutions, CTMS, RTSM & eTMF ) By Development Phase (Phase I, Phase II, Phase III, Phase IV) By Mode Of Delivery (Web Hosted, Licensed Enterprise, Cloud-based) By End Use, Forecasts to 2028
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs